About this document
Cystic Fibrosis Liver Disease and Ursodeoxycholic by Aisyah Putri is a document available to read on EtoBox.
The document discusses the challenges in understanding and treating liver disease in cystic fibrosis (CF) patients, emphasizing the need for better therapeutic endpoints. It highlights the longstanding use of Ursodeoxycholic acid (UDCA) despite insufficient evidence supporting its efficacy, as well as recent studies questioning its safety. The author calls for further investigation into the potential toxicity of UDCA and the need for well-designed studies to improve treatment outcomes for CF-related liver d
- Author
- Aisyah Putri
- Language
- EN